ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

AACR’s First Special Conference Scheduled for Oct. 23-27 at Cape Cod

July 22, 1988